close :

:

Forgotten your password?
 
Pharma Industry News
Printable Version   Email to a friend

CDC issues Health Alert Notice for travelers to USA from Hong Kong, Guangdong Province and Hanoi

CDC issues Health Alert Notice for travelers to USA from Hong Kong, Guangdong Province and Hanoi

ATLANTA, GA., March 17, 2003 -- The Centers for Disease Control and Prevention (CDC) on Saturday began distributing cards at airports receiving flights returning directly from Hong Kong warning travelers returning to the United States from Hong Kong and Guangdong Province, People's Republic of China and Hanoi, Vietnam that they may have been exposed to cases of severe acute respiratory syndrome (SARS).

The cards are being handed out by quarantine officials at Chicago, O'Hare International Airport; Los Angeles; New York City, JFK International Airport; Newark; and San Francisco. These airports are the only U.S. airports receiving direct flights from Hong Kong. No U.S. airports receive direct flights from Hanoi or the Guangdong Province. CDC officials expect to expand the distribution of cards to Anchorage, Alaska and the territory of Guam later today.

The travel cards warn those returning from the three areas that they should monitor their health for at least seven days. They are also advised to contact their physicians if they become ill with a fever accompanied by a cough or difficulty in breathing.

The cards also offer guidance designed to assist physicians in making a diagnosis by advising travelers to tell their physicians about recent travel to the affected regions, and whether they have been in contact with individuals who displayed symptoms of SARS.

As of March 15, 2003, the CDC had received reports of SARS cases in Hong Kong and Guangdong Province, People's Republic of China; Hanoi, Vietnam and Canada, Singapore and Thailand. For that reason the World Health Organization has issued emergency guidance for travelers and airlines so that persons displaying symptoms of the illness can receive immediate health care and can be brought to the attention of public health authorities. These individuals are also advised against traveling while ill.

The CDC advises physicians and other clinicians to be alert for travelers who:

  • Have a fever of 100.4 degrees Fahrenheit or higher;
  • One or more symptoms of respiratory illness including cough, shortness of breath, difficulty in breathing, hypoxia (deficiency in the amount of oxygen reaching tissues of the body), X-rays indicating the presence of pneumonia, or respiratory distress; AND

One or more of the following:

  • History of travel to Hong Kong or Guangdong Province, People's Republic of China, or Hanoi, Vietnam within seven days of symptom onset;
  • Close contact with persons with respiratory illness having the described travel history. Close contact includes having cared for, lived with, or had direct contact with respiratory secretions and body fluids of a person with SARS.

Additionally, airlines should:

  • Alert the destination airport of any passengers meeting the case definition criteria;
  • Arriving passengers who are symptomatic should be referred to health authorities for assessment and care;
  • Aircraft passengers and crew should be informed of the person's status as a suspect case of SARS;
  • The passengers and crew should provide all contact information for how passengers can be reached for the subsequent 14 days to airport health authorities.

CDC advises that persons planning elective or nonessential travel to Hong Kong and Guangdong Province, People's Republic of China and Hanoi, Vietnam may wish to postpone their trips until further notice. Detailed information can be found on CDC's Traveler's Health Website at http://www.cdc.gov/travel

Latest Pharma Industry News...

Pharma Industry News Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

More News Resources


Most Popular Internet Searches
Latest FDA Drug Alerts
July 17, 2008
Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating...
July 16, 2008
Audience: Radiologists, surgeons, hospital risk managers, other healthcare professionals [Posted 07/16/2008] FDA informed...
July 16, 2008
Audience: Pharmacists, hospital risk managers, other healthcare professionals[Posted 07/16/2008] Roxane Laboratories, Inc....
July 14, 2008
Audience: Oncologists, other healthcare professionals[Posted 07/14/2008] Genentech, Inc. informed healthcare professionals of...
More...
Latest Drug Information Updates

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

OraVerse
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.

Aplenzin
Aplenzin is a once-daily formulation of bupropion hydrobromide indicated for the treatment of depression in adults.

Cimzia
Cimzia is a PEGylated anti-TNF (tumor necrosis factor) biologic therapy for the treatment of moderately to severely active Crohn’s disease in adults.

Relistor
subcutaneous injection for the treatment of opioid-induced constipation

Treximet
Treximet is the first and only migraine product designed to target multiple mechanisms of migraine by combining a triptan, a class of migraine-specific medicines, and an anti-inflammatory pain reliever in a single tablet.

Patanase
Patanase (olopatadine) is an antihistamine nasal spray for the treatment of symptoms of seasonal allergic rhinitis in adults and adolescents twelve years of age and older.

Lexiscan
Lexiscan (regadenoson) is an A2A adenosine receptor agonist indicated for use as a pharmacologic stress agent in radionuclide myocardial perfusion imaging (MPI), a test that detects and characterizes coronary artery disease, in patients unable to undergo adequate exercise stress.

More...